| Recruitment status | Completed |
| Unique ID issued by UMIN | C000000423 |
| Receipt No. | R000000507 |
| Official scientific title of the study | Efficacy of mesenchymal stem cells for treatment of refractory acute GVHD after stem cell transplantation |
| Date of disclosure of the study information | 2006/06/01 |
| Last modified on | 2016/06/02 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Efficacy of mesenchymal stem cells for treatment of refractory acute GVHD after stem cell transplantation | |
| Title of the study (Brief title) | Efficacy of mesenchymal stem cells for treatment of refractory acute GVHD | |
| Region |
|
|
| Condition | ||
| Condition | refractoty acute GVHD after stem cell transplantation | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the efficacy of mesenchymal stem cells for treatment of refractory acute GVHD |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | GVHD score |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intravenous injection of mesenchymal stem cells | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) after stem cell transplantation
2) acute GVHD (grade III-IV) 3) refractory or relapsed acute GVHD after steroid therapy 4) written informed consent 5) HLA matched or one locus mismatched donor |
|||
| Key exclusion criteria | 1) in relapse disease status
2) in unconsciousness 3) in severe infection |
|||
| Target sample size | 5 | |||
| Research contact person | |
| Name of lead principal investigator | Keiya Ozawa |
| Organization | Jichi Medical University |
| Division name | Division of Hematology |
| Address | 3311-1 Yakushiji, Shimotsuke-shi, Tochigi |
| TEL | 0285-58-7353 |
| Public contact | |
| Name of contact person | Kazuya Sato |
| Organization | Jichi Medical University |
| Division name | Division of Hematology |
| Address | 3311-1 Yakushiji, Shimotsuke-shi, Tochigi |
| TEL | 0285-58-7353 |
| Homepage URL | |
| kazuya@jichi.ac.jp | |
| Sponsor | |
| Institute | Jichi Medical University, Department of Medicine, Division of Hematology |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Jichi Medical University, Department of Medicine, Division of Hematology |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000000507 |